Read full article on publisher's website“It would be an enormous benefit to pharma and humanity if we had a more efficient and systematic way to bring safe and effective drugs to market,” says Greg Koski Ph.D., M.D., CEO, president and cofounder of the Alliance for Clinical Research Excellence and Safety (ACRES). He asserts that the current approach has evolved into a multisiloed proprietary arrangement.
Everyone knows it’s an inefficient mess, and many believe it’s unsustainable.” He proposes a better approach — a system.
